The Evolution of Illicit-Drug Detection: From Conventional Approaches to Cutting-Edge Immunosensors-A Comprehensive Review.


Journal

Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 06 08 2024
revised: 26 09 2024
accepted: 29 09 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

The increasing use of illicit drugs has become a major global concern. Illicit drugs interact with the brain and the body altering an individual's mood and behavior. As the substance-of-abuse (SOA) crisis continues to spread across the world, in order to reduce trafficking and unlawful activity, it is important to use point-of-care devices like biosensors. Currently, there are certain conventional detection methods, which include gas chromatography (GC), mass spectrometry (MS), surface ionization, surface-enhanced Raman spectroscopy (SERS), surface plasmon resonance (SPR), electrochemiluminescence (ECL), high-performance liquid chromatography (HPLC), etc., for the detection of abused drugs. These methods have the advantage of high accuracy and sensitivity but are generally laborious, expensive, and require trained operators, along with high sample requirements, and they are not suitable for on-site drug detection scenarios. As a result, there is an urgent need for point-of-care technologies for a variety of drugs that can replace conventional techniques, such as a biosensor, specifically an immunosensor. An immunosensor is an analytical device that integrates an antibody-based recognition element with a transducer to detect specific molecules (antigens). In an immunosensor, the highly selective antigen-antibody interaction is used to identify and quantify the target analyte. The binding event between the antibody and antigen is converted by the transducer into a measurable signal, such as electrical, optical, or electrochemical, which corresponds to the presence and concentration of the analyte in the sample. This paper provides a comprehensive overview of various illicit drugs, the conventional methods employed for their detection, and the advantages of immunosensors over conventional techniques. It highlights the critical need for on-site detection and explores emerging point-of-care testing methods. The paper also outlines future research goals in this field, emphasizing the potential of advanced technologies to enhance the accuracy, efficiency, and convenience of drug detection.

Identifiants

pubmed: 39451690
pii: bios14100477
doi: 10.3390/bios14100477
pii:
doi:

Substances chimiques

Illicit Drugs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Jamia Hamdard, Department of Biotechnology (DBT)
ID : BT/PR31594/MED/32/738/2020

Auteurs

Nigar Anzar (N)

Department of Biotechnology, School of Chemical and Life Science, Jamia Hamdard University, New Delhi 110062, India.

Shariq Suleman (S)

Department of Biotechnology, School of Chemical and Life Science, Jamia Hamdard University, New Delhi 110062, India.

Yashda Singh (Y)

Department of Biotechnology, School of Chemical and Life Science, Jamia Hamdard University, New Delhi 110062, India.

Supriya Kumari (S)

Department of Biotechnology, School of Chemical and Life Science, Jamia Hamdard University, New Delhi 110062, India.

Suhel Parvez (S)

Department of Toxicology, School of Chemical and Life Science, Jamia Hamdard University, New Delhi 110062, India.

Roberto Pilloton (R)

National Research Council, Department of Chemical Sciences and Materials Technology, Institute of Crystallography, 00015 Rome, Italy.

Jagriti Narang (J)

Department of Biotechnology, School of Chemical and Life Science, Jamia Hamdard University, New Delhi 110062, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH